{"id":"placebo-of-anagliptin","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1929396","moleculeType":"Small molecule","molecularWeight":"383.46"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Placebos are designed to appear identical to the active drug being tested but contain no active ingredients. They help researchers determine the true effect of the active drug by comparing outcomes against a baseline where no active treatment is given.","oneSentence":"A placebo does not have an active pharmacological mechanism; it is used as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:01.231Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01529528","phase":"PHASE3","title":"A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"JW Pharmaceutical","startDate":"2011-05","conditions":"Type 2 Diabetes Mellitus","enrollment":117}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of Anagliptin","genericName":"Placebo of Anagliptin","companyName":"JW Pharmaceutical","companyId":"jw-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}